Metacrine Price on December 31, 2024
MTCRDelisted Stock | USD 0.49 0.00 0.00% |
If you're considering investing in Metacrine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Metacrine stands at 0.49, as last reported on the 3rd of January, with the highest price reaching 0.52 and the lowest price hitting 0.43 during the day. We have found six technical indicators for Metacrine, which you can use to evaluate the volatility of the firm. Please verify Metacrine's Day Median Price of 0.48, accumulation distribution of 0.17, and Market Facilitation Index of 0.09 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Metacrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Metacrine |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
MTCR |
Based on monthly moving average Metacrine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Metacrine by adding Metacrine to a well-diversified portfolio.
Related Headline
Assembly Biosciences Headline on 31st of December 2024
Darryl Wilson was at the centre of a party row after being overlooked for an Assembly seat.
Metacrine Valuation on December 31, 2024
It is possible to determine the worth of Metacrine on a given historical date. On December 31, 2024 Metacrine was worth 0.49 at the beginning of the trading date compared to the closed value of 0.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Metacrine stock. Still, in general, we apply an absolute valuation method to find Metacrine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Metacrine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Metacrine's related companies.
Open | High | Low | Close | Volume | |
01/03/2025 | 0.49 | 0.52 | 0.43 | 0.49 | 0.00 |
Backtest Metacrine | | | Metacrine History | | | Metacrine Valuation |
Metacrine Trading Date Momentum on December 31, 2024
Metacrine Fundamentals Correlations and Trends
By evaluating Metacrine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Metacrine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Metacrine financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Metacrine Stock history
Metacrine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Metacrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Metacrine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Metacrine stock prices may prove useful in developing a viable investing in Metacrine
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California. Metacrine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Metacrine Stock Technical Analysis
Metacrine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Metacrine Period Price Range
Low | January 3, 2025
| High |
0.00 | 0.00 |
Metacrine cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Metacrine January 3, 2025 Market Strength
Market strength indicators help investors to evaluate how Metacrine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Metacrine shares will generate the highest return on investment. By undertsting and applying Metacrine stock market strength indicators, traders can identify Metacrine entry and exit signals to maximize returns
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Metacrine Stock
If you are still planning to invest in Metacrine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Metacrine's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Valuation Check real value of public entities based on technical and fundamental data |